Advertisement

In Vitro Assays to Determine Smooth Muscle Cell Hypertrophy, Protein Content, and Fibrosis

  • Katherine J. Elliott
  • Satoru Eguchi
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1614)

Abstract

This chapter provides information on how to culture primary rat vascular smooth muscle cells and how to induce cellular changes similar to those associated with angiotensin II activation in vivo. We describe how to assess the cellular changes by determining cell size with an automated coulter cell counter to measure cell volume. In addition, we describe a method to assess total protein content. Finally, we describe a standard technique to quantify angiotensin II-induced pro-fibrotic response using the Chondrex Sirius Red Total Collagen Detection Kit.

Key words

Explant primary cell culture VSMC Angiotensin II Hypertrophy Fibrosis 

References

  1. 1.
    Geisterfer AA, Peach MJ, Owens GK (1988) Angiotensin ii induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749–756CrossRefPubMedGoogle Scholar
  2. 2.
    Eguchi S, Hirata Y, Imai T, Kanno K, Marumo F (1994) Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 134:222–228CrossRefPubMedGoogle Scholar
  3. 3.
    Ohtsu H, Higuchi S, Shirai H, Eguchi K, Suzuki H, Hinoki A, Brailoiu E, Eckhart AD, Frank GD, Eguchi S (2008) Central role of gq in the hypertrophic signal transduction of angiotensin ii in vascular smooth muscle cells. Endocrinology 149:3569–3575CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ross R (1971) The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50:172–186CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Nakashima H, Frank GD, Shirai H, Hinoki A, Higuchi S, Ohtsu H, Eguchi K, Sanjay A, Reyland ME, Dempsey PJ, Inagami T, Eguchi S (2008) Novel role of protein kinase C delta Tyr311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II. Hypertension 51:232–238CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Takayanagi T, Forrester FJ, Kawai T, Obama T, Tsuji T, Elliott KJ, Nuti E, Rossello A, Kwok HF, Scalia R, Rizzo V, Eguchi S (2016) Vascular ADAM17 as a novel therapeutic target in mediating cardiovascular hypertrophy and perivascular fibrosis induced by angiotensin II. Hypertension 68(4):949–955CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  1. 1.Department of Physiology and Cardiovascular Research CenterLewis Katz School of Medicine, Temple UniversityPhiladelphiaUSA

Personalised recommendations